Immunotherapy for Unresectable Stage III Non–Small-Cell Lung Cancer | NEJM
In this issue of the Journal, Antonia and colleagues report the results of the phase 3 PACIFIC study, which evaluated the role of immune checkpoint blockade in locally advanced, unresectable, stage…